Erratum: FRET-based intracellular investigation of nanoprodrugs toward highly efficient anticancer drug delivery (Nanoscale (2020) 12 (16710–16715) DOI: 10.1039/D0NR04910G)

The authors regret that the acknowledgements section had been inadvertently omitted from the original article. The following statement should have been included: Acknowledgements This work was supported by KAKENHI (JP17H03003, JP19KK0136, 19H02785, JP19H02785, JP19K15690, JP20K05413), FWO (G0D4519N, G081916N) and ERC (#280064 to H. U.). Financial support from the KU Leuven (C14/15/053, C14/19/079) and BELSPO (IAP VII/05) is greatly acknowledged. B. F. acknowledges the support from the Research Foundation-Flanders (FWO postdoctoral fellowship: 12X1419N). J. H. gratefully acknowledges support from the Flemish government through long term structural funding Methusalem (CASAS2, Meth/15/04). T. I. acknowledges Iketani Science and Technology Foundation, and Nakatani Foundation. B. F. and T. I. acknowledge the RIES International Exchange Program of "Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials"from MEXT. T. I and H. K. acknowledge the Research Program for CORE lab of "Five-star Alliance"in "NJRC Mater. & Dev.". This work was partially supported by JSPS Core-to-Core Program A and the Photoexcitonix Project in Hokkaido University. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.